China toughens disease law

In the wake of SARS, a revised law ensures funding for infectious disease control

Written byPaul Mooney
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

International observers reacted with cautious optimism this week to news that China's parliament has beefed up its main infectious disease and control law, warning that the law needs to be properly implemented for it to have the desired effect.

"The new legislation sounds sensible–although the devil is always in the detail," said Vivian Lin, head of the School of Public Health, La Trobe University in Australia, and an expert of public health in China.

"From a Western perspective, we'd always be looking for an appropriate balance between coercive powers to protect the public and protection of individual liberties–privacy, autonomy, and confidentiality," she told The Scientist. "It's important to have reserve powers, but how they are exercised and delegated and scrutinized are important."

The Standing Committee of China's National People's Congress responded to last year's SARS outbreaks by passing a revision of the country's Law on the Prevention and Control of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA